Arcellx (ACLX)

• Market cap: $3.8B
• 1 day: -0.44%
• 5 days: 1.84%
• 1 month: -10.29%
• 3 months: -17.61%
• 6 months: 1.45%
• Year to date: -16.56%
• 1 year: -16.84%
• 5 years: 291.13%
• 10 years: 291.13%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163